Gastroenterology Report最新文献

筛选
英文 中文
Perioperative immune-related adverse events in gastric cancer: a new challenge for surgical safety in the era of neoadjuvant immunotherapy. 胃癌围手术期免疫相关不良事件:新辅助免疫治疗时代对手术安全性的新挑战
IF 4.2 3区 医学
Gastroenterology Report Pub Date : 2026-05-01 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag045
Zhouqiao Wu, Jingpu Wang, Ziyu Li, Jiafu Ji
{"title":"Perioperative immune-related adverse events in gastric cancer: a new challenge for surgical safety in the era of neoadjuvant immunotherapy.","authors":"Zhouqiao Wu, Jingpu Wang, Ziyu Li, Jiafu Ji","doi":"10.1093/gastro/goag045","DOIUrl":"https://doi.org/10.1093/gastro/goag045","url":null,"abstract":"","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag045"},"PeriodicalIF":4.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13132655/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147823264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metformin for preventing esophageal stricture after circumferential endoscopic submucosal dissection in a canine model. 二甲双胍预防犬模型经周内镜下粘膜下剥离后食管狭窄。
IF 4.2 3区 医学
Gastroenterology Report Pub Date : 2026-05-01 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag040
Ling Yang, Binbin Xu, Chunwei Fan, Yuju Huang, Li Yu
{"title":"Metformin for preventing esophageal stricture after circumferential endoscopic submucosal dissection in a canine model.","authors":"Ling Yang, Binbin Xu, Chunwei Fan, Yuju Huang, Li Yu","doi":"10.1093/gastro/goag040","DOIUrl":"https://doi.org/10.1093/gastro/goag040","url":null,"abstract":"<p><strong>Background: </strong>Esophageal stricture frequently occur after extensive endoscopic submucosal dissection (ESD). Effective, safe, and straightforward prevention and treatment methods are lacking. This preclinical animal study evaluated the efficacy of metformin in preventing esophageal stricture following ESD using a dog model.</p><p><strong>Methods: </strong>Ten Beagle dogs were randomly divided into the metformin and control groups. Circumferential esophageal ESD was performed 30-33 cm from the incisors. The metformin group received 100 mg/kg/day metformin from the second postoperative day, while the control group received physiological saline by gavage. After 4 weeks, the Beagles were euthanized, and esophageal tissues were collected for macroscopic and pathological evaluations.</p><p><strong>Results: </strong>Four weeks post-ESD, the modified dysphagia scores in the metformin group were lower than the control [1 (1, 2) vs 3 (3, 4), <i>P </i>= 0.041, Cliff's D = -0.80 (-0.97 to -0.14)]. Macroscopic examination showed that the stricture rate in the metformin group was lower than the control [38.60% (32.50%, 44.30%) vs 53.90% (52.30%, 62.00%), <i>P </i>= 0.056, Cliff's D = -0.76 (-0.97 to 0.09)]. Hematoxylin and eosin staining revealed that the re-epithelialization rate in the metformin group was higher than the control [88.30% (85.60%, 90.10%) vs 20.60% (11.20%, 27.40%), <i>P </i>= 0.008, Cliff's D = 1.00 (0.82-1.00)]. Masson's trichrome staining indicated that the submucosal fibrosis in the metformin group was thin and orderly, with a maximum thickness of 863.00 (786.00, 932.00) μm, whereas the control group exhibited disordered fibrosis with a maximum thickness of 1,275.00 (1,266.00, 1,340.00) μm [<i>P </i>= 0.008, Cliff's D = -1.00 (-1.00 to -0.82)].</p><p><strong>Conclusion: </strong>Metformin effectively promoted esophageal wound re-epithelialization after ESD, reduced submucosal fibrosis, and showed a trend toward alleviating esophageal stricture.</p>","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag040"},"PeriodicalIF":4.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13134663/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147822932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First-line nanoparticle polymeric micellar paclitaxel with gemcitabine in metastatic pancreatic cancer: a single-arm, prospective, and exploratory study. 纳米颗粒聚合胶束紫杉醇联合吉西他滨治疗转移性胰腺癌:单臂、前瞻性和探索性研究
IF 4.2 3区 医学
Gastroenterology Report Pub Date : 2026-05-01 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag034
Nan Lyu, Qianqian Wang, Kuirong Jiang, Dong Xu, Yang Wu, Kai Zhang, Jishu Wei, Jianmin Chen, Feng Guo, Zipeng Lu, Bin Xiao, Guosheng Chen, Junli Wu, Wentao Gao, Yuqi Wang, Fufeng Wang, Min Tu
{"title":"First-line nanoparticle polymeric micellar paclitaxel with gemcitabine in metastatic pancreatic cancer: a single-arm, prospective, and exploratory study.","authors":"Nan Lyu, Qianqian Wang, Kuirong Jiang, Dong Xu, Yang Wu, Kai Zhang, Jishu Wei, Jianmin Chen, Feng Guo, Zipeng Lu, Bin Xiao, Guosheng Chen, Junli Wu, Wentao Gao, Yuqi Wang, Fufeng Wang, Min Tu","doi":"10.1093/gastro/goag034","DOIUrl":"https://doi.org/10.1093/gastro/goag034","url":null,"abstract":"<p><strong>Background: </strong>Pancreatic cancer is one of the most lethal malignancies, with limited therapeutic options. In this exploratory trial, we aimed to evaluate the efficacy and safety of nanoparticle polymeric micellar paclitaxel (pm-Pac) combined with gemcitabine as first-line treatment for metastatic pancreatic cancer (mPC).</p><p><strong>Methods: </strong>Twenty-one patients with histologically or cytologically confirmed mPC were enrolled in this study. The primary endpoint was progression-free survival (PFS). Meanwhile, the secondary endpoints included the objective response rate (ORR), overall survival, disease control rate (DCR), duration of response (DOR), and safety of combination therapy.</p><p><strong>Results: </strong>The median PFS was 7.4 months (95% confidence interval [CI]: 5.4-9.4 months). The ORR and DCR were 52.4% (95% CI: 29.1%-75.7%) and 95.2% (95% CI: 85.3%-100%), respectively. Amongst patients who achieved partial response, the median DOR was 4.8 months (95% CI: 1.5-8.1 months). No treatment-related deaths were reported. Grade 3-4 adverse events (AEs) occurred in 81.0% of patients, with increased γ-glutamyltransferase levels (38.1%), neutropenia (33.3%), and leukocytopenia (28.6%) being the most frequent AEs. Low SERPINB3 and SERPINB4 expression was correlated with prolonged PFS, accompanied by the significant downregulation of gene sets involved in DNA replication, nonsense-mediated mRNA decay, and protein translation in long-PFS tumours. Tumour immune microenvironment analysis revealed that patients with short PFS had increased levels of common lymphoid progenitors and decreased populations of mature B and T lymphocytes.</p><p><strong>Conclusions: </strong>The combination of pm-Pac and gemcitabine as first-line therapy for mPC exhibited favourable tolerability and clinical efficacy. However, larger randomized-controlled trials are needed to validate these preliminary findings.</p><p><strong>Trial registration: </strong>www.chictr.org.cn, ChiCTR2300078861.</p>","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag034"},"PeriodicalIF":4.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13132657/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147823521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natural history, clinical associations, and management issues of idiopathic sclerosing mesenteritis: a prospective cohort study. 特发性硬化性肠系炎的自然史、临床关联和管理问题:一项前瞻性队列研究。
IF 4.2 3区 医学
Gastroenterology Report Pub Date : 2026-04-25 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag035
Christina Liava, Danai Chourmouzi, Emmanouil Sinakos, Georgia Gioula, Evangelos Akriviadis
{"title":"Natural history, clinical associations, and management issues of idiopathic sclerosing mesenteritis: a prospective cohort study.","authors":"Christina Liava, Danai Chourmouzi, Emmanouil Sinakos, Georgia Gioula, Evangelos Akriviadis","doi":"10.1093/gastro/goag035","DOIUrl":"https://doi.org/10.1093/gastro/goag035","url":null,"abstract":"","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag035"},"PeriodicalIF":4.2,"publicationDate":"2026-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13109999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147789158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multisystem toxicity and non-cirrhotic portal hypertension linked to arsenic exposure from a traditional herbal preparation. 多系统毒性和非肝硬化门静脉高压症与砷暴露的传统草药制剂有关。
IF 4.2 3区 医学
Gastroenterology Report Pub Date : 2026-04-25 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag036
You Deng, Guanhua Zhang, Weijia Duan, Xinyan Zhao
{"title":"Multisystem toxicity and non-cirrhotic portal hypertension linked to arsenic exposure from a traditional herbal preparation.","authors":"You Deng, Guanhua Zhang, Weijia Duan, Xinyan Zhao","doi":"10.1093/gastro/goag036","DOIUrl":"https://doi.org/10.1093/gastro/goag036","url":null,"abstract":"","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag036"},"PeriodicalIF":4.2,"publicationDate":"2026-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13109998/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147789161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Partial splenic infarction after endoscopic hemostasis: a case report. 内镜止血后部分脾梗死1例。
IF 4.2 3区 医学
Gastroenterology Report Pub Date : 2026-04-23 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag029
Qing Li, Xiaocun Xing, Jiahuan Liu, Xue Xiao
{"title":"Partial splenic infarction after endoscopic hemostasis: a case report.","authors":"Qing Li, Xiaocun Xing, Jiahuan Liu, Xue Xiao","doi":"10.1093/gastro/goag029","DOIUrl":"https://doi.org/10.1093/gastro/goag029","url":null,"abstract":"","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag029"},"PeriodicalIF":4.2,"publicationDate":"2026-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13105837/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147789238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic therapy for multifocal early esophageal cancer complicated by esophageal varices: a case report. 内镜治疗多灶性早期食管癌合并食管静脉曲张1例。
IF 4.2 3区 医学
Gastroenterology Report Pub Date : 2026-04-21 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag038
Yanbin Wei, Zinan Zhang, Jiafei Peng, Fuliang He, Lixue Xu, Xin Yao, Peng Li, Jie Xing
{"title":"Endoscopic therapy for multifocal early esophageal cancer complicated by esophageal varices: a case report.","authors":"Yanbin Wei, Zinan Zhang, Jiafei Peng, Fuliang He, Lixue Xu, Xin Yao, Peng Li, Jie Xing","doi":"10.1093/gastro/goag038","DOIUrl":"https://doi.org/10.1093/gastro/goag038","url":null,"abstract":"","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag038"},"PeriodicalIF":4.2,"publicationDate":"2026-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13099638/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147789227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Type 1 autoimmune pancreatitis presenting with exophytic pancreatic mass formation and ascites: a case report. 1型自身免疫性胰腺炎表现为外生性胰腺肿块形成和腹水:1例报告。
IF 4.2 3区 医学
Gastroenterology Report Pub Date : 2026-04-20 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag030
Yusuke Kitera, Junichi Kaneko, Shioto Suzuki, Daijiro Suzuki, Kohei Nishizawa, Yuichi Hirano, Shinya Ikeda, Takuya Otsu, Masaki Takinami, Yurimi Takahashi, Yuzo Sasada, Kazuhito Kawata, Satoshi Tamura
{"title":"Type 1 autoimmune pancreatitis presenting with exophytic pancreatic mass formation and ascites: a case report.","authors":"Yusuke Kitera, Junichi Kaneko, Shioto Suzuki, Daijiro Suzuki, Kohei Nishizawa, Yuichi Hirano, Shinya Ikeda, Takuya Otsu, Masaki Takinami, Yurimi Takahashi, Yuzo Sasada, Kazuhito Kawata, Satoshi Tamura","doi":"10.1093/gastro/goag030","DOIUrl":"https://doi.org/10.1093/gastro/goag030","url":null,"abstract":"","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag030"},"PeriodicalIF":4.2,"publicationDate":"2026-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13094541/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147789250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of long-term outcomes between endoscopic submucosal dissection and esophagectomy for superficial esophageal squamous cell carcinoma. 内镜下粘膜下剥离与食管切除术治疗浅表性食管鳞状细胞癌的远期疗效比较。
IF 4.2 3区 医学
Gastroenterology Report Pub Date : 2026-04-19 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag032
Byeong Yun Ahn, Quanxin Zheng, Soo-Jeong Cho, Sang Gyun Kim, Chang Hyun Kang, Hyunsoo Chung
{"title":"Comparison of long-term outcomes between endoscopic submucosal dissection and esophagectomy for superficial esophageal squamous cell carcinoma.","authors":"Byeong Yun Ahn, Quanxin Zheng, Soo-Jeong Cho, Sang Gyun Kim, Chang Hyun Kang, Hyunsoo Chung","doi":"10.1093/gastro/goag032","DOIUrl":"https://doi.org/10.1093/gastro/goag032","url":null,"abstract":"<p><strong>Background: </strong>Endoscopic submucosal dissection (ESD) is increasingly being performed as a less invasive alternative to esophagectomy for superficial esophageal squamous cell carcinoma (SESCC); however, comparative long-term outcome data, especially for non-curative resection (non-CR) cases and elderly patients, remain limited. This study aimed to compare the clinical outcomes of ESD and esophagectomy using a propensity score (PS)-matched cohort.</p><p><strong>Methods: </strong>Patients with SESCC who underwent ESD or esophagectomy at a tertiary referral center between 2011 and 2021 were retrospectively reviewed. In the PS-matched cohort, overall survival (OS), disease-specific survival (DSS), recurrence-free survival (RFS), additional treatments, and adverse events were compared. Subgroup analyses were conducted for non-CR cases and elderly patients (≥70 years).</p><p><strong>Results: </strong>Among the 63 PS-matched pairs, OS, DSS, and RFS were comparable between the ESD and esophagectomy groups. The 5-year OS, DSS, and RFS rates were 89.9% versus 79.2%, 95.7% versus 94.4%, and 90.6% versus 89.1%, respectively. The ESD group had significantly fewer adverse events (47.6% vs 68.3%, <i>P </i>< 0.05) and a shorter median hospital stay (1.0 vs 10.0 days, <i>P </i>< 0.001) than the esophagectomy group. Survival outcomes were also similar in the non-CR and elderly subgroups.</p><p><strong>Conclusions: </strong>ESD is a safe and effective alternative to esophagectomy for SESCC, including in non-CR and elderly patients. Given the limitations of preprocedural depth assessment and the high risk of complications associated with esophagectomy, staging ESD for SESCC may represent a reasonable treatment option, particularly for elderly or high-risk patients.</p>","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag032"},"PeriodicalIF":4.2,"publicationDate":"2026-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13092296/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147730728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrated endoscopy: a new method for improving the diagnostic accuracy of Helicobacter pylori infection status. 综合内镜:提高幽门螺杆菌感染状态诊断准确性的新方法。
IF 4.2 3区 医学
Gastroenterology Report Pub Date : 2026-03-29 eCollection Date: 2026-02-01 DOI: 10.1093/gastro/goag027
Dong Yang, Nan Zhang, Ke Tao, Meng Li, Hong Xu
{"title":"Integrated endoscopy: a new method for improving the diagnostic accuracy of <i>Helicobacter pylori</i> infection status.","authors":"Dong Yang, Nan Zhang, Ke Tao, Meng Li, Hong Xu","doi":"10.1093/gastro/goag027","DOIUrl":"10.1093/gastro/goag027","url":null,"abstract":"<p><strong>Aim: </strong>We proposed an integrated endoscopic strategy and compared it with conventional methods to assess whether it improves the diagnostic accuracy of <i>Helicobacter pylori</i> infection status.</p><p><strong>Methods: </strong>A retrospective cohort (between 1 August 2022 and 30 April 2024; <i>n</i> = 163) was used to compare white light endoscopy (WLE) and magnifying endoscopy (ME) and to prespecify the integrated endoscopy (IE) algorithm. IE first uses ME to grade the proportion of fundic crypt openings and then applies WLE features to classify <i>H. pylori</i> status. A prospective cohort (between 1 May 2024 and 30 December 2024; <i>n</i> = 221) applied the locked IE algorithm and compared its performance with WLE and ME. The primary outcome was overall diagnostic accuracy; secondary outcomes were accuracy for each infection status category.</p><p><strong>Results: </strong>In the retrospective cohort, IE achieved higher overall accuracy than WLE and ME (79.8% vs 69.9% and 71.8%, respectively), with improved accuracy for negative (85.4%) and eradicated status (72.5%). ME was more accurate than WLE for negative (82.9% vs 61.0%) and eradicated status (62.7% vs 52.9%), whereas WLE was more accurate for positive status (87.3% vs 71.8%). In the prospective cohort, IE again showed the highest overall accuracy (86.4% vs 70.6% for WLE and 72.9% for ME), with higher accuracy for negative (90.7%) and eradicated status (92.4%), while WLE maintained higher accuracy for positive status (89.8% vs 78.4% for IE).</p><p><strong>Conclusion: </strong>IE that combines ME-based fundic crypt opening assessment with WLE features may improve endoscopic classification of overall, negative, and eradicated <i>H. pylori</i> infection status compared with WLE or ME alone. These findings support IE as a promising diagnostic approach that warrants further multicenter confirmation. (ClinicalTrials.gov, NCT06397066.).</p>","PeriodicalId":54275,"journal":{"name":"Gastroenterology Report","volume":"14 ","pages":"goag027"},"PeriodicalIF":4.2,"publicationDate":"2026-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13033319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147582531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书